title: Group II metabotropic glutamate receptors and schizophrenia.
abstract: Schizophrenia is one of the most common mental illnesses, with hereditary and environmental factors important for its etiology. All antipsychotics have in common a high affinity for monoaminergic receptors. Whereas hallucinations and delusions usually respond to typical (haloperidol-like) and atypical (clozapine-like) monoaminergic antipsychotics, their efficacy in improving negative symptoms and cognitive deficits remains inadequate. In addition, devastating side effects are a common characteristic of monoaminergic antipsychotics. Recent biochemical, preclinical and clinical findings support group II metabotropic glutamate receptors (mGluR2 and mGluR3) as a new approach to treat schizophrenia. This paper reviews the status of general knowledge of mGluR2 and mGluR3 in the psychopharmacology, genetics and neuropathology of schizophrenia.
authors.affiliation: Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: José L
authors.initials: JL
authors.lastname: Moreno
authors.forename: Stuart C
authors.initials: SC
authors.lastname: Sealfon
authors.forename: Javier
authors.initials: J
authors.lastname: González-Maeso
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000493:pharmacokinetics; D006801:Humans; D051379:Mice; D008954:Models, Biological; D018094:Receptors, Metabotropic Glutamate / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D012559:Schizophrenia / Q000378:metabolism*
chemical_list: D014150:Antipsychotic Agents; D018094:Receptors, Metabotropic Glutamate; C108822:metabotropic glutamate receptor 2; C102718:metabotropic glutamate receptor 3
references.citation: Br J Pharmacol. 2006 Apr;147(8):839-53
references.pmid: 16474411
references.citation: J Neurochem. 2009 Jun;109(5):1497-507
references.pmid: 19344374
references.citation: Hum Genet. 2007 Feb;120(6):889-906
references.pmid: 17006672
references.citation: Nature. 2008 Sep 11;455(7210):237-41
references.pmid: 18668038
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):48-55
references.pmid: 17097347
references.citation: J Psychiatry Neurosci. 2001 Mar;26(2):137-49
references.pmid: 11291531
references.citation: Pharmacol Rev. 2005 Jun;57(2):279-88
references.pmid: 15914470
references.citation: Neuron. 2006 Oct 5;52(1):139-53
references.pmid: 17015232
references.citation: Trends Neurosci. 2009 Apr;32(4):225-32
references.pmid: 19269047
references.citation: Eur Neuropsychopharmacol. 2008 Oct;18(10):768-72
references.pmid: 18614340
references.citation: Am J Psychiatry. 2002 Jul;159(7):1080-92
references.pmid: 12091183
references.citation: Am J Psychiatry. 2008 Dec;165(12):1594-603
references.pmid: 18923069
references.citation: Neurochem Res. 2002 Oct;27(10):957-80
references.pmid: 12462398
references.citation: Biol Psychiatry. 2000 Jan 1;47(1):22-8
references.pmid: 10650445
references.citation: Biol Psychiatry. 2007 Oct 1;62(7):747-55
references.pmid: 17531207
references.citation: Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2660-5
references.pmid: 11867751
references.citation: Science. 2007 Jan 26;315(5811):525-8
references.pmid: 17185560
references.citation: Pharmacol Rev. 2007 Mar;59(1):5-13
references.pmid: 17329545
references.citation: Ann Clin Psychiatry. 2005 Jul-Sep;17(3):137-40
references.pmid: 16433054
references.citation: Psychiatr Genet. 2007 Dec;17(6):358
references.pmid: 18075480
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12536-41
references.pmid: 17636131
references.citation: Mol Psychiatry. 2005 Jan;10(1):27-39
references.pmid: 15340352
references.citation: Annu Rev Med. 2001;52:503-17
references.pmid: 11160792
references.citation: Nat Genet. 1998 Sep;20(1):70-3
references.pmid: 9731535
references.citation: Pharmacol Res. 2008 Sep-Oct;58(3-4):240-6
references.pmid: 18790058
references.citation: Annu Rev Pharmacol Toxicol. 1997;37:205-37
references.pmid: 9131252
references.citation: Schizophr Bull. 2008 Nov;34(6):1083-94
references.pmid: 18635675
references.citation: Biochem Pharmacol. 2004 Oct 15;68(8):1565-72
references.pmid: 15451400
references.citation: Mol Psychiatry. 2002;7(2):157-64
references.pmid: 11840308
references.citation: Am J Med Genet. 2000 Spring;97(1):23-44
references.pmid: 10813802
references.citation: J Clin Psychiatry. 1999;60 Suppl 12:22-3
references.pmid: 10372606
references.citation: Nat Med. 2007 Sep;13(9):1102-7
references.pmid: 17767166
references.citation: Expert Rev Neurother. 2008 Sep;8(9):1389-406
references.pmid: 18759551
references.citation: Neuropsychopharmacology. 2008 Oct;33(11):2626-34
references.pmid: 18256595
references.citation: Schizophr Res. 2005 Feb 1;73(1):21-6
references.pmid: 15567072
references.citation: AMA Arch Neurol Psychiatry. 1954 Feb;71(2):227-37
references.pmid: 13123588
references.citation: Am J Psychiatry. 2006 Jul;163(7):1273-6
references.pmid: 16816234
references.citation: Psychiatr Genet. 2008 Feb;18(1):25-30
references.pmid: 18197082
references.citation: Neuropsychopharmacology. 2008 Aug;33(9):2206-16
references.pmid: 17957214
references.citation: Psychopharmacology (Berl). 2005 Apr;179(1):303-9
references.pmid: 15309376
references.citation: Eur J Pharmacol. 2000 May 26;397(1):R1-2
references.pmid: 10844118
references.citation: Pharmacol Rev. 2008 Sep;60(3):358-403
references.pmid: 18922967
references.citation: EMBO J. 2001 May 1;20(9):2152-9
references.pmid: 11331581
references.citation: Cell Physiol Biochem. 2007;20(6):687-702
references.pmid: 17982252
references.citation: Genomics. 1996 Jan 15;31(2):230-3
references.pmid: 8824806
references.citation: Biol Psychiatry. 2004 May 15;55(10):965-70
references.pmid: 15121478
references.citation: Biochemistry. 2005 Jul 12;44(27):9395-403
references.pmid: 15996094
references.citation: Pharmacol Ther. 2003 Jun;98(3):325-54
references.pmid: 12782243
references.citation: N Engl J Med. 2003 Oct 30;349(18):1738-49
references.pmid: 14585943
references.citation: Neuropsychopharmacology. 2000 Nov;23(5):569-76
references.pmid: 11027922
references.citation: Eur Neuropsychopharmacol. 2008 Jun;18(6):395-405
references.pmid: 18063347
references.citation: Schizophr Res. 2006 Dec;88(1-3):260-4
references.pmid: 16904291
references.citation: Mol Psychiatry. 2008 Jul;13(7):673-84
references.pmid: 17684500
references.citation: Mol Psychiatry. 2001 Mar;6(2):186-92
references.pmid: 11317221
references.citation: J Psychopharmacol. 2008 May;22(3):308-22
references.pmid: 18541626
references.citation: J Biol Chem. 2006 Apr 28;281(17):11917-22
references.pmid: 16495215
references.citation: Hist Psychiatry. 2007 Mar;18(1):39-60
references.pmid: 17580753
references.citation: Trends Pharmacol Sci. 2008 Sep;29(9):445-53
references.pmid: 19086254
references.citation: Trends Pharmacol Sci. 1999 Jul;20(7):294-301
references.pmid: 10390648
references.citation: Synapse. 2005 Sep 1;57(3):123-31
references.pmid: 15945063
references.citation: Brain Res Mol Brain Res. 1998 May;56(1-2):207-17
references.pmid: 9602129
references.citation: Behav Brain Res. 2009 Dec 7;204(2):313-21
references.pmid: 19136031
references.citation: Mol Psychiatry. 2005 Jan;10(1):79-104
references.pmid: 15289815
references.citation: Neuron. 2007 Feb 1;53(3):439-52
references.pmid: 17270739
references.citation: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11940-5
references.pmid: 12189203
references.citation: J Pharmacol Exp Ther. 2007 Feb;320(2):944-50
references.pmid: 17135347
references.citation: Mol Psychiatry. 2008 Sep;13(9):873-7
references.pmid: 18195713
references.citation: Cell Tissue Res. 2006 Nov;326(2):483-504
references.pmid: 16847639
references.citation: Curr Med Chem. 2009;16(8):1017-27
references.pmid: 19275609
references.citation: Harv Rev Psychiatry. 2006 May-Jun;14(3):152-64
references.pmid: 16787887
references.citation: Biotechniques. 2006 May;40(5):601-2, 604, 606, passim
references.pmid: 16708760
references.citation: Arch Gen Psychiatry. 2003 Dec;60(12):1187-92
references.pmid: 14662550
references.citation: Mol Psychiatry. 2008 May;13(5):470-9
references.pmid: 18268502
references.citation: Mol Psychiatry. 2005 Jan;10(1):69-78
references.pmid: 15381925
references.citation: J Biol Chem. 2001 Oct 19;276(42):39053-9
references.pmid: 11489900
references.citation: Nature. 2008 Mar 6;452(7183):93-7
references.pmid: 18297054
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12604-9
references.pmid: 15310849
references.citation: Curr Opin Pharmacol. 2004 Feb;4(1):18-22
references.pmid: 15018834
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):392-6
references.pmid: 17948896
references.citation: J Neurochem. 2006 Feb;96(4):1139-48
references.pmid: 16417579
references.citation: Am J Med Genet. 2002 Jan 8;114(1):12-4
references.pmid: 11840499
references.citation: Am J Med Genet. 2000 Dec 4;96(6):749-53
references.pmid: 11121174
references.citation: Nat Rev Drug Discov. 2009 Jan;8(1):41-54
references.pmid: 19116626
references.citation: Am J Med Genet. 1998 Jul 10;81(4):290-5
references.pmid: 9674973
references.citation: Nature. 2000 Oct 26;407(6807):971-7
references.pmid: 11069170
references.citation: EMBO Rep. 2004 Jan;5(1):30-4
references.pmid: 14710183
references.citation: Mol Pharmacol. 2007 Aug;72(2):477-84
references.pmid: 17526600
references.citation: Schizophr Bull. 2007 Sep;33(5):1100-19
references.pmid: 17617664
references.citation: Nat Genet. 1995 Nov;11(3):321-4
references.pmid: 7581457
references.citation: Schizophr Res. 2005 Sep 15;77(2-3):253-60
references.pmid: 15913960
references.citation: Biochim Biophys Acta. 2007 Apr;1768(4):825-35
references.pmid: 17069751
references.citation: Science. 1998 Aug 28;281(5381):1349-52
references.pmid: 9721099
references.citation: Nat Rev Genet. 2008 Jul;9(7):527-40
references.pmid: 18560438
references.citation: J Pharmacol Exp Ther. 2008 Jul;326(1):209-17
references.pmid: 18424625
references.citation: Pharmacol Ther. 2004 Jul;103(1):21-80
references.pmid: 15251227
references.citation: Ann N Y Acad Sci. 2008;1136:185-92
references.pmid: 18579882
references.citation: Curr Protoc Neurosci. 2007 Apr;Chapter 9:Unit 9.24
references.pmid: 18428667
references.citation: Mol Med. 2003 Jan-Feb;9(1-2):3-9
references.pmid: 12765334
references.citation: Psychopharmacology (Berl). 2008 Feb;196(3):431-40
references.pmid: 18057917
references.citation: BMC Psychiatry. 2005 May 13;5:23
references.pmid: 15892884
references.citation: CNS Drugs. 2007;21(11):911-36
references.pmid: 17927296
references.citation: Am J Med Genet. 2002 Jan 8;114(1):46-50
references.pmid: 11840505
references.citation: J Biol Chem. 2007 May 18;282(20):14875-81
references.pmid: 17395586
references.citation: Hum Mol Genet. 2000 Apr 12;9(7):1049-57
references.pmid: 10767329
references.citation: Am J Hum Genet. 2005 Dec;77(6):918-36
references.pmid: 16380905
references.citation: Mol Psychiatry. 2005 Jan;10(1):40-68; image 5
references.pmid: 15263907
references.citation: Am J Psychiatry. 2009 Jul;166(7):812-20
references.pmid: 19487395
references.citation: Nat Struct Mol Biol. 2004 Aug;11(8):706-13
references.pmid: 15235591
references.citation: Nat Methods. 2008 Jun;5(6):561-7
references.pmid: 18488035
references.citation: Am J Psychiatry. 2006 Apr;163(4):740-2
references.pmid: 16585454
references.citation: Mol Psychiatry. 2008 Jan;13(1):27-35
references.pmid: 17848919
references.citation: J Biol Chem. 2007 Nov 9;282(45):33000-8
references.pmid: 17855348
references.citation: Trends Pharmacol Sci. 2009 Jan;30(1):25-31
references.pmid: 19058862
references.citation: Proc Natl Acad Sci U S A. 2007 May 1;104(18):7682-7
references.pmid: 17452637
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10859-64
references.pmid: 17578920
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1071-9
references.pmid: 14642967
references.citation: Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:83-96
references.pmid: 12504074
references.citation: Psychiatr Genet. 2003 Jun;13(2):71-6
references.pmid: 12782962
references.citation: Int J Neurosci. 2008 Nov;118(11):1609-27
references.pmid: 18853337
references.citation: J Pharmacol Exp Ther. 2005 Dec;315(3):1181-7
references.pmid: 16123306
references.citation: J Neurosci. 2003 Oct 1;23(26):8836-43
references.pmid: 14523084
references.citation: J Pharmacol Exp Ther. 2000 Jan;292(1):2-7
references.pmid: 10604925